The acetate and valeric acid produced by probiotics inhibit the development of MAFLD‐related HCC by binding to the hepatocyte GPR43 receptor and downregulating the activity of the IL‐6–JAK–STAT3 and Rho–GTPase pathways, respectively [57, 58]. This evidence concerns the gene RHO and hepatocellular carcinoma.